{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:26:23Z","timestamp":1789748783528,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T00:00:00Z","timestamp":1464998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Novartis Germany","award":["SVOT-004"],"award-info":[{"award-number":["SVOT-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00406-016-0703-8","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T17:04:33Z","timestamp":1465059873000},"page":"455-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus"],"prefix":"10.1007","volume":"267","author":[{"given":"Miriam","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sch\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"R\u00f6\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5338-2765","authenticated-orcid":false,"given":"Robert","family":"Waltereit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,4]]},"reference":[{"key":"703_CR1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","volume":"368","author":"G Baird","year":"2006","unstructured":"Baird G, Simonoff E, Pickles A et al (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368:210\u2013215","journal-title":"Lancet"},{"key":"703_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(02)00160-6","volume":"1","author":"R Tuchman","year":"2002","unstructured":"Tuchman R, Rapin I (2002) Epilepsy in autism. Lancet Neurol 1:352\u2013358","journal-title":"Lancet Neurol"},{"key":"703_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ (2015) Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 14:733\u2013745. doi: 10.1016\/S1474-4422(15)00069-1","journal-title":"Lancet Neurol"},{"key":"703_CR4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","volume":"14","author":"D Ehninger","year":"2008","unstructured":"Ehninger D, Han S, Shilyansky C et al (2008) Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis. Nat Med 14:843\u2013848","journal-title":"Nat Med"},{"key":"703_CR5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nature11310","volume":"488","author":"PT Tsai","year":"2013","unstructured":"Tsai PT, Hull C, Chu Y et al (2013) Autistic-like behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488:647\u2013651","journal-title":"Nature"},{"key":"703_CR6","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/ncomms2295","volume":"3","author":"A Sato","year":"2012","unstructured":"Sato A, Kasai S, Kobayashi T et al (2012) Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun 3:1292. doi: 10.1038\/ncomms2295","journal-title":"Nat Commun"},{"key":"703_CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1469-8749.1981.tb02063.x","volume":"23","author":"R Riikonen","year":"1981","unstructured":"Riikonen R, Amnell G (1981) Psychiatric disorders in children with earlier infantile spasms. Dev Med Child Neurol 23:747\u2013760","journal-title":"Dev Med Child Neurol"},{"key":"703_CR8","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1528-1167.2006.00888.x","volume":"47","author":"ZR Primec","year":"2006","unstructured":"Primec ZR, Stare J, Neubauer D (2006) The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia 47:2202\u20132205","journal-title":"Epilepsia"},{"key":"703_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.wnl.0000168908.78118.99","volume":"65","author":"S Goh","year":"2005","unstructured":"Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA (2005) Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 65:235\u2013238","journal-title":"Neurology"},{"key":"703_CR10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/adc.2003.026815","volume":"89","author":"FJ O\u2019Callaghan","year":"2004","unstructured":"O\u2019Callaghan FJ, Harris T, Joinson C et al (2004) The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 89:530\u2013533","journal-title":"Arch Dis Child"},{"key":"703_CR11","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1523\/JNEUROSCI.5746-12.2013","volume":"33","author":"AD Workman","year":"2013","unstructured":"Workman AD, Charvet CJ, Clancy B et al (2013) Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci 33:7368\u20137383. doi: 10.1523\/JNEUROSCI.5746-12.2013","journal-title":"J Neurosci"},{"key":"703_CR12","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1046\/j.1460-9568.2000.00117.x","volume":"12","author":"M Lynch","year":"2000","unstructured":"Lynch M, Sayin U, Bownds J et al (2000) Long-term consequences of early postnatal seizures on hippocampal learning and plasticity. Eur J Neurosci 12:2252\u20132264","journal-title":"Eur J Neurosci"},{"key":"703_CR13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.0013-9580.2004.54903.x","volume":"45","author":"U Sayin","year":"2004","unstructured":"Sayin U, Sutula TP, Stafstrom CE (2004) Seizures in the developing brain cause adverse long-term effects on spatial learning and anxiety. Epilepsia 45:1539\u20131548","journal-title":"Epilepsia"},{"key":"703_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.283.5398.70","volume":"283","author":"C Ikonomidou","year":"1999","unstructured":"Ikonomidou C, Bosch F, Miksa M et al (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70\u201374","journal-title":"Science"},{"key":"703_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bbr.2011.10.052","volume":"227","author":"AL Lim","year":"2012","unstructured":"Lim AL, Taylor DA, Malone DT (2012) Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research. Behav Brain Res 227:276\u2013286. doi: 10.1016\/j.bbr.2011.10.052","journal-title":"Behav Brain Res"},{"key":"703_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1460-9568.2006.04594.x","volume":"23","author":"C Brelie von der","year":"2006","unstructured":"von der Brelie C, Waltereit R, Zhang L et al (2006) Impaired synaptic plasticity in a rat model of tuberous sclerosis. Eur J Neurosci 23:686\u2013692. doi: 10.1111\/j.1460-9568.2006.04594.x","journal-title":"Eur J Neurosci"},{"key":"703_CR17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2005.03538.x","volume":"96","author":"R Waltereit","year":"2006","unstructured":"Waltereit R, Welzl H, Dichgans J et al (2006) Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis. J Neurochem 96:407\u2013413","journal-title":"J Neurochem"},{"key":"703_CR18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10519-010-9399-0","volume":"41","author":"R Waltereit","year":"2011","unstructured":"Waltereit R, Japs B, Schneider M et al (2011) Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behav Genet 41:364\u2013372","journal-title":"Behav Genet"},{"key":"703_CR19","first-page":"5645","volume":"62","author":"HL Kenerson","year":"2002","unstructured":"Kenerson HL, Aicher LD, True LD, Yeung RS (2002) Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer Res 62:5645\u20135650","journal-title":"Cancer Res"},{"key":"703_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","volume":"57","author":"H Kenerson","year":"2005","unstructured":"Kenerson H, Dundon TA, Yeung RS (2005) Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 57:67\u201375. doi: 10.1203\/01.PDR.0000147727.78571.07","journal-title":"Pediatr Res"},{"key":"703_CR21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00280-009-1068-8","volume":"65","author":"T O\u2019Reilly","year":"2009","unstructured":"O\u2019Reilly T, McSheehy PMJ, Kawai R et al (2009) Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents. Cancer Chemother Pharmacol 65:625\u2013639","journal-title":"Cancer Chemother Pharmacol"},{"key":"703_CR22","doi-asserted-by":"crossref","first-page":"15629","DOI":"10.1073\/pnas.95.26.15629","volume":"95","author":"G Rennebeck","year":"1998","unstructured":"Rennebeck G, Kleymenova EV, Anderson R et al (1998) Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA 95:15629\u201315634","journal-title":"Proc Natl Acad Sci USA"},{"key":"703_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1369-1600.2008.00117.x","volume":"13","author":"M Schneider","year":"2008","unstructured":"Schneider M, Schomig E, Leweke FM (2008) Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict Biol 13:345\u2013357","journal-title":"Addict Biol"},{"key":"703_CR24","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","volume":"28","author":"L Meikle","year":"2008","unstructured":"Meikle L, Pollizzi K, Egnor A et al (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28:5422\u20135432. doi: 10.1523\/JNEUROSCI.0955-08.2008","journal-title":"J Neurosci"},{"key":"703_CR25","volume-title":"Rutter\u2019s child and adolescent psychiatry","author":"M Rutter","year":"2010","unstructured":"Rutter M, Bishop D, Pine D et al (2010) Rutter\u2019s child and adolescent psychiatry, 5th edn. Wiley-Blackwell, Hoboken","edition":"5"},{"key":"703_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40810-015-0004-x","volume":"1","author":"R Ishii","year":"2015","unstructured":"Ishii R, Wataya-Kaneda M, Canuet L et al (2015) Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report. Neuropsychiatr Electrophysiol 1:6. doi: 10.1186\/s40810-015-0004-x","journal-title":"Neuropsychiatr Electrophysiol"},{"key":"703_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu-Shore","year":"2010","unstructured":"Chu-Shore CJ, Major P, Camposano S et al (2010) The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 51:1236\u20131241. doi: 10.1111\/j.1528-1167.2009.02474.x","journal-title":"Epilepsia"},{"key":"703_CR28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1176\/ajp.136.10.1310","volume":"136","author":"EY Deykin","year":"1979","unstructured":"Deykin EY, MacMahon B (1979) The incidence of seizures among children with autistic symptoms. Am J Psychiatry 136:1310\u20131312","journal-title":"Am J Psychiatry"},{"key":"703_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1469-8749.2012.04223.x","volume":"54","author":"S Woolfenden","year":"2012","unstructured":"Woolfenden S, Sarkozy V, Ridley G et al (2012) A systematic review of two outcomes in autism spectrum disorder\u2014epilepsy and mortality. Dev Med Child Neurol 54:306\u2013312. doi: 10.1111\/j.1469-8749.2012.04223.x","journal-title":"Dev Med Child Neurol"},{"key":"703_CR30","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s11910-011-0195-x","volume":"11","author":"R Tuchman","year":"2011","unstructured":"Tuchman R, Cuccaro M (2011) Epilepsy and autism: neurodevelopmental perspective. Curr Neurol Neurosci Rep 11:428\u2013434. doi: 10.1007\/s11910-011-0195-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"703_CR31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1026052421693","volume":"28","author":"SL Smalley","year":"1998","unstructured":"Smalley SL (1998) Autism and tuberous sclerosis. J Autism Dev Disord 28:407\u2013414","journal-title":"J Autism Dev Disord"},{"key":"703_CR32","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195122107.001.0001","volume-title":"The tuberous sclerosis complex","author":"MR Gomez","year":"1999","unstructured":"Gomez MR, Sampson JR, Whittemore VH (1999) The tuberous sclerosis complex. Oxford University Press, New York"},{"key":"703_CR33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc062928","volume":"356","author":"PJ Vries de","year":"2007","unstructured":"de Vries PJ, Prather PA (2007) The tuberous sclerosis complex. N Engl J Med 356:92","journal-title":"N Engl J Med"},{"key":"703_CR34","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.21331","volume":"63","author":"L-H Zeng","year":"2008","unstructured":"Zeng L-H, Xu L, Gutmann DH, Wong M (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 63:444\u2013453. doi: 10.1002\/ana.21331","journal-title":"Ann Neurol"},{"key":"703_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","volume":"74","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Wilfong AA, Holland-Bouley K et al (2013) Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 74:679\u2013687. doi: 10.1002\/ana.23960","journal-title":"Ann Neurol"},{"key":"703_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/ern.13.48","volume":"13","author":"M Wong","year":"2013","unstructured":"Wong M (2013) A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials. Expert Rev Neurother 13:657\u2013669. doi: 10.1586\/ern.13.48","journal-title":"Expert Rev Neurother"},{"key":"703_CR37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ Vries de","year":"2007","unstructured":"de Vries PJ, Howe CJ (2007) The tuberous sclerosis complex proteins\u2014a GRIPP on cognition and neurodevelopment. Trends Mol Med 13:319\u2013326","journal-title":"Trends Mol Med"},{"key":"703_CR38","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","volume":"53","author":"D Ehninger","year":"2009","unstructured":"Ehninger D, de Vries PJ, Silva AJ (2009) From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res 53:838\u2013851","journal-title":"J Intellect Disabil Res"},{"key":"703_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.braindev.2008.09.013","volume":"31","author":"V Napolioni","year":"2009","unstructured":"Napolioni V, Moavero R, Curatolo P (2009) Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev 31:104\u2013113. doi: 10.1016\/j.braindev.2008.09.013","journal-title":"Brain Dev"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-016-0703-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0703-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-016-0703-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T10:38:44Z","timestamp":1718620724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-016-0703-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,4]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1007\/s00406-016-0703-8","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,4]]}}}